ZYME - Company ID 0001937653
The table below shows Zymeworks Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $105.97M | $76.30M | $76.01M | $412.48M | $26.68M | $38.95M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | $143.62M | $208.60M | $199.75M | $171.20M |
| SG&A |
Zymeworks Inc. reported annual revenue of $105.97M for fiscal year 2025. That is up 38.9% from $76.30M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $38.95M (FY 2020) to $105.97M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $61.51M |
| $61.51M |
| $70.45M |
| $73.36M |
| $42.56M |
| $55.22M |
| Operating income | -$92.55M | -$137.11M | -$138.05M | $130.53M | -$215.63M | -$187.47M |
| Income tax | $1.38M | $6.08M | -$568.00K | $10.89M | -$516.00K | $429.00K |
| Net income | -$81.13M | -$122.69M | -$118.67M | $124.34M | -$211.84M | -$180.55M |
| EPS (diluted) | -$1.08 | -$1.62 | -$1.72 | $1.90 | -$4.61 | -$3.58 |